Contract to supply NHS

Advanced Medical Solutions Grp PLC 27 January 2005 For Immediate Release Thursday, 27 January 2005 Advanced Medical Solutions Group plc ('AMS' or 'the Company') Inclusion on contract to supply wound management products to NHS Hospitals in Scotland Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global woundcare technology company, is pleased to announce that it has been selected by Scottish Healthcare Supplies, the procurement service to the NHS in Scotland, for inclusion on a contract for supply of woundcare products. The award follows an in-depth technical and clinical evaluation in a major Scottish NHS Hospital Trust and covers a range of AMS' advanced wound dressings, which will be sold under the ActivHeal(R) brand by the Company's MedLogic direct sales and marketing team. The inclusion of ActivHeal(R) is a response to cost constraints on woundcare budgets whereby savings made on standard products for routine wounds allow funding of higher technology products for problematic wounds. AMS' strategy is to fulfil the demand for these standard products by selling either directly, as in the UK, or via private label partners whilst continuing to sell its differentiated products through its major woundcare partners under their leading brands. As a UK-based technology company, AMS is ideally placed to become a new generation woundcare supplier through a balance of innovation and cost management by integrating with the end user. This benefits both parties and allows significant cost savings to be achieved by the NHS along the lines of the highly successful generic pharmaceutical model. Commenting on today's announcement, Dr. Don Evans, Chief Executive of AMS, said: 'I am delighted that we have been selected for the supply of our products into NHS hospitals in Scotland. This is another major step forward in strengthening our UK presence as part of broadening our routes to market. 'Following on from the inclusion of our products on the NHS contract for hospitals in England announced in December 2004, and previous Drug Tariff approvals allowing our products to be prescribed in England, Wales and Scotland, this latest award means that our ActivHeal(R) woundcare brand is now widely available for sale into hospitals, nursing homes and community care throughout the NHS in the UK.' For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508 Don Evans, Chief Executive Mary Tavener, Finance Director www.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000 Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development and manufacture of products for the $15 billion global woundcare market. Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative and technologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS's resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move from product design and development through to production and delivery ready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology in cyanoacrylate based tissue adhesives that offer benefits over sutures and staples for closing wounds sold direct to hospitals or through distributors. AMS's technology and products currently serve the majority of the key global markets with strategic partners including 3M, Novartis, Johnson & Johnson, Molnlycke Healthcare, Smith + Nephew and Cardinal Health. This information is provided by RNS The company news service from the London Stock Exchange
UK 100